Skip to main content

RxSight, Inc.

RXST
Exchange
Nasdaq
Industry
Ophthalmic Goods
SEC CIK
0001111485

In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by RxSight, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
4 insiders, $118.0K in total
Insiders trading
4
Net value
−$118.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for RxSight, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for RxSight, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Weinberg EricSee remarks235,516Sep 16, 20264
Wilterding MarkChief Financial Officer25,049Sep 9, 20264
Kurtz Ronald M MDChief Medical Officer71,775Sep 9, 20263
Goldshleger IlyaChief Operating Officer81,509Sep 9, 20264
Mottiwala AzizPresident and CEO–Jul 24, 20261
Palmisano Robert JDirector78,076Jun 18, 20261
Link William J PhDDirector74,892Jun 18, 20261
Cohen Raymond WDirector66,532Jun 18, 20261
Tammenoms Bakker JulietDirector85,183Jun 18, 20261
Andrews JulieDirector78,076Jun 18, 20261
Maniar ShwetaDirector55,172Jun 18, 20261
Warner Robert KeithDirector78,076Jun 18, 20261
Corley Jesse AndersonDirector86,227Jun 18, 20261
Fountain TamaraDirector72,582Jun 18, 20261
Gaines ScottChief Customer Officer14,848Mar 3, 20261
Thunen Shelley BSee remarks38,354Apr 15, 20250
Robertson Bruce CDirector1,385,037IndirectAug 5, 20210
RxSight I, LLC10% Owner2,016,778Aug 5, 20210
Wolfen Richard M.Director1,762,074IndirectAug 5, 20210
Schwartz Daniel MarkDirector407,647Aug 5, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 9, 2024 (view filing)Jan 81 dayWarner Robert KeithDirectorSSale−23.8K$42.69−$1.01M−100.0%0 after2 lots10b5-1
Jan 9, 2024 (view filing)Jan 81 dayManiar ShwetaDirectorSSale−6.42K$45.00−$288.8K−25.7%18.5K after10b5-1
Jan 9, 2024 (view filing)Jan 81 dayKurtz Ronald M MDPresident & CEOSSale−62.5K$44.25−$2.77M−7.2%804.6K after2 lots10b5-1
Jan 9, 2024 (view filing)Jan 81 dayGoldshleger IlyaChief Operating OfficerSSale−15.0K$43.33−$650.0K−36.2%26.5K after3 lots10b5-1
Jan 9, 2024 (view filing)Jan 81 dayCorley Jesse AndersonDirectorSSale−2.00K$45.03−$90.1K−14.7%11.6K after10b5-1
Jan 3, 2024 (view filing)Jan 21 dayThunen Shelley BChief Financial OfficerSSale−10.0K$39.24−$392.4K−81.4%2.29K after2 lots10b5-1
Dec 29, 2023 (view filing)Dec 272 daysKurtz Ronald M MDPresident & CEOSSale−22.5K$41.09−$924.5K−2.5%867.1K after10b5-1
Dec 26, 2023 (view filing)Dec 224 daysWeinberg EricChief Commercial OfficerSSale−1.28K$40.00−$51.4K−0.4%340.0K after
Dec 26, 2023 (view filing)Dec 224 daysGoldshleger IlyaChief Operating OfficerSSale−5.00K$40.00−$200.0K−15.9%26.5K after
Dec 20, 2023 (view filing)Dec 182 daysGoldshleger IlyaChief Operating OfficerSSale−10.9K$39.01−$426.7K−29.2%26.5K after4 lots10b5-1
Dec 19, 2023 (view filing)Dec 154 daysWeinberg EricChief Commercial OfficerSSale−8.71K$40.01−$348.7K−2.5%341.3K after10b5-1
Dec 18, 2023 (view filing)Dec 153 daysThunen Shelley BChief Financial OfficerSSale−20.0K$39.35−$787.0K−89.7%2.29K after10b5-1
Dec 18, 2023 (view filing)Dec 153 daysThunen Shelley BChief Financial OfficerSSale−20.0K$39.32−$786.3K−41.3%28.4K after2 lots10b5-1
Dec 18, 2023 (view filing)Dec 144 daysCorley Jesse AndersonDirectorSSale−12.0K$40.12−$481.4K−46.8%13.6K after2 lots10b5-1
Dec 18, 2023 (view filing)Dec 144 daysKurtz Ronald M MDPresident & CEOSSale−40.0K$39.71−$1.59M−4.3%889.6K after2 lots10b5-1
Dec 12, 2023 (view filing)Dec 8-114 daysWarner Robert KeithDirectorSSale−20.0K$35.03−$700.6K−45.7%23.8K after2 lots10b5-1
Nov 30, 2023 (view filing)Nov 28-292 daysTammenoms Bakker JulietDirectorSSale−494.3K$29.73−$14.7M−100.0%0 after2 lots
Nov 16, 2023 (view filing)Nov 14-152 daysTammenoms Bakker JulietDirectorSSale−500.0K$27.19−$13.6M−50.3%494.3K after2 lots
Sep 11, 2023 (view filing)Sep 7-114 daysTammenoms Bakker JulietDirectorSSale−33.0K$30.14−$993.0K−62.0%20.2K after3 lots
Aug 29, 2023 (view filing)Aug 29Same dayManiar ShwetaDirectorSSale−4.29K$28.06−$120.4K−14.7%24.9K after10b5-1
Aug 28, 2023 (view filing)Aug 253 daysTammenoms Bakker JulietDirectorSSale−16.2K$29.25−$474.1K−23.4%53.2K after
Aug 18, 2023 (view filing)Aug 17-181 dayTammenoms Bakker JulietDirectorSSale−33.1K$29.62−$981.5K−32.6%68.4K after2 lots
Feb 13, 2023 (view filing)Feb 103 daysTammenoms Bakker JulietDirectorPPurchase+480.0K$12.50+$6.00M+96.0%980.0K after
Nov 18, 2021 (view filing)Nov 171 dayCorley Jesse AndersonDirectorPPurchase+8.15K$12.49+$101.8K+139.1%14.0K after
Aug 6, 2021 (view filing)Aug 51 dayGoldshleger IlyaChief Operating OfficerPPurchase+1.00K$14.49+$14.5KNew position1.00K after
Aug 6, 2021 (view filing)Aug 51 dayGoldshleger IlyaChief Operating OfficerPPurchase+1.37K$13.69+$18.8KNew position1.37K after
Aug 6, 2021 (view filing)Jul 30-Aug 57 daysLateWeinberg EricChief Commercial OfficerPPurchase+925$16.47+$15.2KNew position925 after5 lots
Aug 5, 2021 (view filing)Aug 32 daysTammenoms Bakker JulietDirectorPPurchase+12.5K$16.00+$200.0K+213.3%18.4K after
Aug 5, 2021 (view filing)Aug 32 daysTammenoms Bakker JulietDirectorPPurchase+625.0K$16.00+$10.0MNew position500.0K after2 lots
Aug 5, 2021 (view filing)Aug 32 daysCorley Jesse AndersonDirectorPPurchase+78.1K$16.00+$1.25M+21.8%436.2K after
Aug 5, 2021 (view filing)Aug 32 daysLink William J PhDDirector, 10% OwnerPPurchase+31.3K$16.00+$500.0K+533.4%37.1K after
Aug 5, 2021 (view filing)Aug 32 daysWeinberg EricChief Commercial OfficerPPurchase+31.3K$16.00+$500.0KNew position31.3K after
Aug 5, 2021 (view filing)Aug 32 daysKurtz Ronald M MDSee RemarksPPurchase+125.0K$16.00+$2.00MNew position125.0K after
Aug 5, 2021 (view filing)Aug 5Same dayKurtz Ronald M MDSee RemarksPPurchase+3.64K$13.85+$50.4K+0.5%804.6K after
Aug 5, 2021 (view filing)Aug 32 daysAndrews JulieDirectorPPurchase+15.6K$16.00+$250.0K+116.8%29.0K after
Aug 5, 2021 (view filing)Aug 32 daysWarner Robert KeithDirectorPPurchase+43.8K$16.00+$700.0K+327.0%57.1K after